Reshmey Medical Clinic Family Medicine San Antonio, TX - 78258

Reshmey Medical Clinic Family Medicine is categorized under Clinics in San Antonio, TX and active since 2007.

Reshmey Medical Clinic Family Medicine was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Reshmey Tharakan at the company’s single location by writing to 1202 East Sonterra Boulevard # 301, San Antonio, Texas TX 78258 or by phoning (210) 828-2311. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Reshmey Medical Clinic Family Medicine
Contact Person: Reshmey Tharakan
Address: 1202 East Sonterra Boulevard # 301, San Antonio, Texas 78258
Phone Number: (210) 828-2311
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Reshmey Medical Clinic Family Medicine was started in 2007 to provide professional Clinics under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Reshmey Tharakan for inquiries that concern Reshmey Medical Clinic Family Medicine by calling the company number (210) 828-2311, as your correspondence is most welcome. Additionally, the physical location of the single location of Reshmey Medical Clinic Family Medicine can be found at the coordinates 29.614372,-98.47462 as well as the street address 1202 East Sonterra Boulevard # 301 in San Antonio, Texas 78258.

For its online presence, you may visit Reshmey Medical Clinic Family Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.